Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_assertion description "[Monocytic MLL-AF9 expressing cells (MM6, THP-1) were hypersensitive to both small-molecule inhibitors targeting Rac1 (EHT 1864, NSC 23766) (IC50EHT�~12.5�?M) and lipid lowering drugs (lovastatin, atorvastatin) (IC50Lova�~7.5�?M) as compared to acute myelocytic leukemia (NOMO-1, HL60) and T cell leukemia (Jurkat) cells (IC50EHT�>30�?M; IC50Lova�>25�?M).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_assertion evidence source_evidence_literature NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_assertion SIO_000772 23624644 NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_assertion wasDerivedFrom befree-20140225 NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_assertion wasGeneratedBy ECO_0000203 NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.
- befree-20140225 importedOn "2014-02-25" NP389182.RA5mVuUVo_SUd0O-7wGqFG2me-x6smRQ9vBAkN8O7DU3Q130_provenance.